Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Keating Litton

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The Oncologist|April 26, 2012
Is age still the deciding factor? Commentary on "The effect of age on delay in diagnosis and stage of breast cancer" by Partridge et alJennifer Keating Litton
Therapeutic Advances in Medical Oncology|May 17, 2012
Exemestane in the prevention settingJennifer Keating Litton, Therese B Bevers, Banu K Arun
Expert Opinion on Pharmacotherapy|January 17, 2012
Aromatase inhibitors and breast cancer preventionJennifer Keating Litton, Banu K Arun, Powel H Brown, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 22, 2025
Multicancer Early Detection Tests at a Crossroads: Commercial Availability Ahead of Definitive EvidenceCarmen E Guerra, Jennifer Keating Litton, Carolina E Viswanath, et al.
Cancer|August 18, 2015
High incidence of germline BRCA mutation in patients with ER low-positive/PR low-positive/HER-2 neu negative tumorsRachel A Sanford, Juhee Song, Angelica M Gutierrez-Barrera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2011
Response to neoadjuvant systemic therapy for breast cancer in BRCA mutation carriers and noncarriers: a single-institution experienceBanu Arun, Soley Bayraktar, Diane D Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2013
Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancerSriram Yennurajalingam, Susan Frisbee-Hume, J Lynn Palmer, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The Oncologist|April 26, 2012
Is age still the deciding factor? Commentary on "The effect of age on delay in diagnosis and stage of breast cancer" by Partridge et alJennifer Keating Litton
Therapeutic Advances in Medical Oncology|May 17, 2012
Exemestane in the prevention settingJennifer Keating Litton, Therese B Bevers, Banu K Arun
Expert Opinion on Pharmacotherapy|January 17, 2012
Aromatase inhibitors and breast cancer preventionJennifer Keating Litton, Banu K Arun, Powel H Brown, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 22, 2025
Multicancer Early Detection Tests at a Crossroads: Commercial Availability Ahead of Definitive EvidenceCarmen E Guerra, Jennifer Keating Litton, Carolina E Viswanath, et al.
Cancer|August 18, 2015
High incidence of germline BRCA mutation in patients with ER low-positive/PR low-positive/HER-2 neu negative tumorsRachel A Sanford, Juhee Song, Angelica M Gutierrez-Barrera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2011
Response to neoadjuvant systemic therapy for breast cancer in BRCA mutation carriers and noncarriers: a single-institution experienceBanu Arun, Soley Bayraktar, Diane D Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2013
Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancerSriram Yennurajalingam, Susan Frisbee-Hume, J Lynn Palmer, et al.
Pageof 1